Saurabh G. Vispute
Dr. Saurabh Vispute is a Principal Scientist at Pfizer contributing to the safety assessment of novel biopharmaceuticals. Prior to his career at Pfizer, Dr. Vispute was a Research Scientist in Toxicology Department at Charles River Laboratories, Reno, NV. He was primarily involved in design, conduct, interpretation, and reporting of toxicology studies. Prior to joining Charles River, Dr. Vispute earned his doctorate in Pharmacology from St. John’s University, New York in 2015. His graduate research focused on characterizing the regulation of Fibroblast growth factor (Fgf) 21 and its pharmacological/toxicological implications. Dr. Vispute is a registered Pharmacist with a Bachelor’s degree in Pharmacy from Mumbai University, India (2009). He is an author/co-author of several publications in peer reviewed journals and presentations at international scientific meetings. Dr. Vispute’s achievements have been recognized by scientific organizations and he is recipient of graduate student awards, scholarships, early career toxicologist awards, and ToxScholar grants. In addition, Dr. Vispute volunteers as a reviewer for peer‑reviewed journals and scientific abstract screening committees. He is actively involved in leadership positions in various component groups and committees within Society of Toxicology and American College of Toxicology.